BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9618240)

  • 1. Glibenclamide does not prevent action potential shortening induced by ischemia in anesthetized rabbits but reduces ischemia-induced arrhythmias.
    Barrett TD; Walker MJ
    J Mol Cell Cardiol; 1998 May; 30(5):999-1008. PubMed ID: 9618240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glibenclamide attenuates the antiarrhythmic effect of endotoxin with a mechanism not involving K(ATP) channels.
    Iskit AB; Erkent U; Ertunc M; Guc MO; Ilhan M; Onur R
    Vascul Pharmacol; 2007 Feb; 46(2):129-36. PubMed ID: 17064967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saralasin suppresses arrhythmias in an isolated guinea pig ventricular free wall model of simulated ischemia and reperfusion.
    Thomas GP; Howlett SE; Ferrier GR
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1379-86. PubMed ID: 7562511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RSD1019 suppresses ischaemia-induced monophasic action potential shortening and arrhythmias in anaesthetized rabbits.
    Barrett TD; MacLeod BA; Walker MJ
    Br J Pharmacol; 2000 Oct; 131(3):405-14. PubMed ID: 11015289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits.
    Das B; Sarkar C; Karanth KS
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):383-96. PubMed ID: 11692221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic and extracellular ionic changes during acute ischemia in failing and normal rabbit myocardium.
    Vermeulen JT; Tan HL; Rademaker H; Schumacher CA; Loh P; Opthof T; Coronel R; Janse MJ
    J Mol Cell Cardiol; 1996 Jan; 28(1):123-31. PubMed ID: 8745220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite change with ischaemia in the antifibrillatory effects of class I and class IV antiarrhythmic drugs resulting from the alteration in ion transmembrane exchanges related to depolarization.
    Aupetit JF; Bui-Xuan B; Kioueh I; Loufoua J; Frassati D; Timour Q
    Can J Physiol Pharmacol; 2000 Mar; 78(3):208-16. PubMed ID: 10721812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model.
    Aidonidis I; Poyatzi A; Stamatiou G; Lymberi M; Stamatoyannis N; Molyvdas PA
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):222-30. PubMed ID: 19587223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of benzyltetrahydropalmatine on ischemia reperfusion with monophasic action potential].
    Xia GJ; Yao WX; Liu XK; Jiang MX
    Yao Xue Xue Bao; 1990; 25(4):293-6. PubMed ID: 2281790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressed monophasic action potential alternans before the onset of ventricular arrhythmias induced by intracoronary bolus administration of endothelin-1 in dogs.
    Merkely B; Vágó H; Kiss O; Zima E; Szücs G; Gellér L; Juhász-Nagy A
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():219S-222S. PubMed ID: 12193090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic effect of acute oxygen-ozone administration to rats.
    Di Filippo C; Cervone C; Rossi C; di Ronza C; Marfella R; Capodanno P; Luongo C; Rossi F; D'Amico M
    Eur J Pharmacol; 2010 Mar; 629(1-3):89-95. PubMed ID: 19958767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of ATP-sensitive potassium channels by 5-hydroxydecanoate suppresses monophasic action potential shortening during regional myocardial ischemia.
    Moritani K; Miyazaki T; Miyoshi S; Asanagi M; Zhao LS; Mitamura H; Ogawa S
    Cardiovasc Drugs Ther; 1994 Oct; 8(5):749-56. PubMed ID: 7873472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible prevention by amlodipine of ventricular fibrillation related to brief ischemia episodes.
    Timour Q; Aupetit JF; Freysz M; Frassati D; Faucon G
    Can J Physiol Pharmacol; 1996 Dec; 74(12):1308-14. PubMed ID: 9047040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic preconditioning and arrhythmogenesis in the rabbit heart: effects on epicardium versus endocardium.
    Botsford MW; Lukas A
    J Mol Cell Cardiol; 1998 Sep; 30(9):1723-33. PubMed ID: 9769228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATP-sensitive potassium channel blocker HMR 1883 reduces mortality and ischemia-associated electrocardiographic changes in pigs with coronary occlusion.
    Wirth KJ; Rosenstein B; Uhde J; Englert HC; Busch AE; Schölkens BA
    J Pharmacol Exp Ther; 1999 Nov; 291(2):474-81. PubMed ID: 10525061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective action of fentanyl in a model of central sympathetic overactivity in rabbits: antiarrhythmic and anti-ischemic effects.
    Lessa MA; Rodrigues E; Tibiricá E
    Acta Anaesthesiol Scand; 2004 Oct; 48(9):1115-22. PubMed ID: 15352957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study.
    Vaillant F; Timour Q; Descotes J; Manati W; Belhani D; Bui-Xuan B; Tabib A; Bricca G; Chevalier P
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):548-54. PubMed ID: 19034029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
    Bui-Xuan B; Aupetit JF; Freysz M; Faucon G; Timour Q
    Pharmacotherapy; 1997; 17(4):737-45. PubMed ID: 9250551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
    Aupetit JF; Loufoua-Moundanga J; Faucon G; Timour Q
    Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.